Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jillian B. Thomsen currently holds 313,497 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jillian B. Thomsen has been a net seller of NKTR stock. They have purchased $0 and sold $11.8M worth of shares.
Jillian B. Thomsen's most recent insider trade was on Feb 16, 2023, when they sold 10,267 shares at $3.00 per share.
Jillian B. Thomsen serves as Executive at NEKTAR THERAPEUTICS (NKTR). They have executed 79 insider transactions totaling $11.8M over their tenure at the company.
Jillian B. Thomsen holds the position of Executive at NEKTAR THERAPEUTICS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Jillian B. Thomsen has shown a selling trading pattern, with $0 in total purchases and $11.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jillian B. Thomsen was on Mar 20, 2017, when they sold $2.2M worth of NKTR shares. This transaction involved 112,500 shares at $19.69 per share.
Jillian B. Thomsen currently owns 313,497 shares of NEKTAR THERAPEUTICS (NKTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jillian B. Thomsen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jillian B. Thomsen has 79 Form 4 filings on record as an insider at NEKTAR THERAPEUTICS.
Set alerts for Jillian B. Thomsen and 40,000+ other insiders.